Kodiak Sciences Inc. financial data

Symbol
KOD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1200 Page Mill Rd, Palo Alto, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Oligasis, LLC (to 7/28/2009)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 604 % -24.9%
Debt-to-equity 78.7 % +48.7%
Return On Equity -81.1 % -20.7%
Return On Assets -45.4 % -3.32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.5 M shares +0.34%
Common Stock, Shares, Outstanding 52.5 M shares +0.34%
Entity Public Float 222 M USD -8.33%
Common Stock, Value, Issued 5 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 52.5 M shares +0.33%
Weighted Average Number of Shares Outstanding, Diluted 52.5 M shares +0.33%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 180 M USD -27.5%
General and Administrative Expense 69.1 M USD -4.48%
Operating Income (Loss) -249 M USD +22.3%
Net Income (Loss) Attributable to Parent -233 M USD +24.7%
Earnings Per Share, Basic -4.44 USD/shares +24.9%
Earnings Per Share, Diluted -4.44 USD/shares +24.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 246 M USD -22.3%
Marketable Securities, Current 0 USD -100%
Assets, Current 252 M USD -41.7%
Property, Plant and Equipment, Net 116 M USD -13.9%
Operating Lease, Right-of-Use Asset 52.6 M USD -11.1%
Other Assets, Noncurrent 8.7 M USD -5.39%
Assets 435 M USD -32.1%
Accounts Payable, Current 2.49 M USD -60.3%
Employee-related Liabilities, Current 5.68 M USD +74.7%
Accrued Liabilities, Current 12.8 M USD -76.7%
Liabilities, Current 24.9 M USD -63.9%
Operating Lease, Liability, Noncurrent 68.7 M USD -12.8%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 194 M USD -21.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.2 B USD -24.2%
Stockholders' Equity Attributable to Parent 241 M USD -38.6%
Liabilities and Equity 435 M USD -32.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.6 M USD +16.1%
Net Cash Provided by (Used in) Financing Activities 38 K USD
Net Cash Provided by (Used in) Investing Activities -166 K USD -100%
Common Stock, Shares Authorized 490 M shares 0%
Common Stock, Shares, Issued 52.5 M shares +0.34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 373 M USD +7.39%
Deferred Tax Assets, Gross 386 M USD +5.03%
Operating Lease, Liability 81.6 M USD -6.95%
Depreciation 4.7 M USD +23.4%
Payments to Acquire Property, Plant, and Equipment 22 K USD -99.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -233 M USD +24.7%
Lessee, Operating Lease, Liability, to be Paid 105 M USD -10.6%
Property, Plant and Equipment, Gross 143 M USD +127%
Operating Lease, Liability, Current 9.61 M USD +20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.3 M USD +8.64%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8 M USD -5.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23.3 M USD -16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.6 M USD +7.17%
Deferred Tax Assets, Operating Loss Carryforwards 134 M USD +14.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 8.25 M USD +8.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.84 M USD -38.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 12.2 M USD -37.2%
Share-based Payment Arrangement, Expense 81 M USD -22.1%
Interest Expense 9 K USD -47.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%